Cargando…

The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2

Long noncoding RNAs (lncRNAs) are emerging as important regulators during tumorigenesis by serving as competing endogenous RNAs (ceRNAs). In this study, the qRT-PCR results indicated that the lncRNA protein disulfide isomerase family A member 3 pseudogene 1 (PDIA3P) was overexpressed in oral squamou...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Cheng-Cao, Zhang, Ling, Li, Guang, Li, Shu-Jun, Chen, Zhen-Long, Fu, Yun-Feng, Gong, Feng-Yun, Bai, Tao, Zhang, Ding-Yu, Wu, Qing-Ming, Li, De-Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626923/
https://www.ncbi.nlm.nih.gov/pubmed/29246288
http://dx.doi.org/10.1016/j.omtn.2017.08.015
_version_ 1783268625315004416
author Sun, Cheng-Cao
Zhang, Ling
Li, Guang
Li, Shu-Jun
Chen, Zhen-Long
Fu, Yun-Feng
Gong, Feng-Yun
Bai, Tao
Zhang, Ding-Yu
Wu, Qing-Ming
Li, De-Jia
author_facet Sun, Cheng-Cao
Zhang, Ling
Li, Guang
Li, Shu-Jun
Chen, Zhen-Long
Fu, Yun-Feng
Gong, Feng-Yun
Bai, Tao
Zhang, Ding-Yu
Wu, Qing-Ming
Li, De-Jia
author_sort Sun, Cheng-Cao
collection PubMed
description Long noncoding RNAs (lncRNAs) are emerging as important regulators during tumorigenesis by serving as competing endogenous RNAs (ceRNAs). In this study, the qRT-PCR results indicated that the lncRNA protein disulfide isomerase family A member 3 pseudogene 1 (PDIA3P) was overexpressed in oral squamous cell carcinoma (OSCC) and decreased the survival rate of OSCC patients. CCK-8 and clonal colony formation assays were used to detect the effects of PDIA3P on proliferation. Results revealed that silencing PDIA3P by small interfering RNA (siRNA) inhibited OSCC cell proliferation and repressed tumor growth and reduced the expression of proliferation antigen Ki-67 in vivo. Furthermore, the interaction between PDIA3P and miRNAs was then analyzed by qRT-PCR and luciferase reporter gene assay. We found that PDIA3P negatively regulated miR-185-5p in OSCC cells. Simultaneously, we found that silencing PDIA3P by siRNA suppressed proliferation via miR-185-5p in OSCC cells. Moreover, silencing PDIA3P by siRNA inhibited CCND2 protein (no influence on mRNA levels) expression via miR-185-5p in OSCC cells, and CCND2 facilitated cell proliferation of SCC4 and SCC15 cells induced by sh-PDIA3P#1. Therefore, our study demonstrated that PDIA3P may be a therapeutic target for the treatment of OSCC.
format Online
Article
Text
id pubmed-5626923
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-56269232017-10-10 The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 Sun, Cheng-Cao Zhang, Ling Li, Guang Li, Shu-Jun Chen, Zhen-Long Fu, Yun-Feng Gong, Feng-Yun Bai, Tao Zhang, Ding-Yu Wu, Qing-Ming Li, De-Jia Mol Ther Nucleic Acids Original Article Long noncoding RNAs (lncRNAs) are emerging as important regulators during tumorigenesis by serving as competing endogenous RNAs (ceRNAs). In this study, the qRT-PCR results indicated that the lncRNA protein disulfide isomerase family A member 3 pseudogene 1 (PDIA3P) was overexpressed in oral squamous cell carcinoma (OSCC) and decreased the survival rate of OSCC patients. CCK-8 and clonal colony formation assays were used to detect the effects of PDIA3P on proliferation. Results revealed that silencing PDIA3P by small interfering RNA (siRNA) inhibited OSCC cell proliferation and repressed tumor growth and reduced the expression of proliferation antigen Ki-67 in vivo. Furthermore, the interaction between PDIA3P and miRNAs was then analyzed by qRT-PCR and luciferase reporter gene assay. We found that PDIA3P negatively regulated miR-185-5p in OSCC cells. Simultaneously, we found that silencing PDIA3P by siRNA suppressed proliferation via miR-185-5p in OSCC cells. Moreover, silencing PDIA3P by siRNA inhibited CCND2 protein (no influence on mRNA levels) expression via miR-185-5p in OSCC cells, and CCND2 facilitated cell proliferation of SCC4 and SCC15 cells induced by sh-PDIA3P#1. Therefore, our study demonstrated that PDIA3P may be a therapeutic target for the treatment of OSCC. American Society of Gene & Cell Therapy 2017-09-21 /pmc/articles/PMC5626923/ /pubmed/29246288 http://dx.doi.org/10.1016/j.omtn.2017.08.015 Text en © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Sun, Cheng-Cao
Zhang, Ling
Li, Guang
Li, Shu-Jun
Chen, Zhen-Long
Fu, Yun-Feng
Gong, Feng-Yun
Bai, Tao
Zhang, Ding-Yu
Wu, Qing-Ming
Li, De-Jia
The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2
title The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2
title_full The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2
title_fullStr The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2
title_full_unstemmed The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2
title_short The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2
title_sort lncrna pdia3p interacts with mir-185-5p to modulate oral squamous cell carcinoma progression by targeting cyclin d2
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626923/
https://www.ncbi.nlm.nih.gov/pubmed/29246288
http://dx.doi.org/10.1016/j.omtn.2017.08.015
work_keys_str_mv AT sunchengcao thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT zhangling thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT liguang thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT lishujun thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT chenzhenlong thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT fuyunfeng thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT gongfengyun thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT baitao thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT zhangdingyu thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT wuqingming thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT lidejia thelncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT sunchengcao lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT zhangling lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT liguang lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT lishujun lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT chenzhenlong lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT fuyunfeng lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT gongfengyun lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT baitao lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT zhangdingyu lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT wuqingming lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2
AT lidejia lncrnapdia3pinteractswithmir1855ptomodulateoralsquamouscellcarcinomaprogressionbytargetingcyclind2